City

Hackensack (1)

Condition

Chronic Lymphocytic Leukemia(CLL) (1)

Small Lymphocytic Lymphoma (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Hackensack Meridian Health (1)

Collaborator

Celgene Corporation (1)

Intervention

azacitidine (1)

revlimid (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

chronic lymphocytic leukemia(cll)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)

Terminated

Chronic Lymphocytic Leukemia(CLL)
Small Lymphocytic Lymphoma

Hackensack, New Jersey

Hackensack University Medical Center

Jun 24, 2022